Vaccine Immunotherapy for Prostate Cancer. Addendum

Abstract

We have successfully submitted clinical trial documents to regulatory agencies following a long interaction with the DOD following their approval of a three year clinical trial award.. We have received an exemption from the RAC and are awaiting final approval by the DOD s HSRRB, the University of Iowa s IRB, and the FDA.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2007
Accession Number
ADA474462

Entities

People

  • David M. Lubaroff

Organizations

  • University of Iowa

Tags

DTIC Thesaurus Topics

  • Chemistry
  • Health Services
  • Lymphocytes
  • Medical Personnel
  • Vaccines

Fields of Study

  • Medicine

Readers

  • Clinical Trial Research.
  • Oncology (Cancer Research).

Technology Areas

  • Biotechnology